The report "Glioblastoma Multiforme Treatment Market by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region - Global Forecasts to 2030", is projected to reach USD 2.85 billion in 2023, having grown at a Compound Annual Growth Rate (CAGR) of 9.9% during the forecast period...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian